MIAMI, USA – BARRANQUILLA, COL – May 17, 2022 – Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it has entered into a definitive agreement to acquire Grupo Somar (including Grupo Farmacéutico Somar and Química y Farmacia and, Gelcaps and related entities) from Advent International (“Advent”), one of the world’s largest private equity investors. Grupo Somar is an integrated pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic, private label and OTC products targeted to the private market and offering CDMO services across key market segments in Mexico. Grupo Somar offers a diversified portfolio of products across key categories and has strong R&D and manufacturing capabilities, operating six modern production facilities (two of which […]
Procaps Group to acquire Grupo Somar from Advent International, gaining an important presence in Mexico, the region´s second largest market
Related
Articles & Interviews
A deliberate and inclusive path to influence: The 10th anniversary of the Adrienne Arsht Latin America Center at the Atlantic Council
Over the past ten years, one of the defining...
Articles & Interviews
The secret of success of the Adrienne Arsht Latin American Center at the Atlantic Council: How to build relevance by fostering socioeconomic prosperity
The mission of the Adrienne Arsht Latin American Center...
Articles & Interviews
Ten years of impactful work in the region: The Adrienne Arsht Latin American Center at the Atlantic Council
A decade ago, when the Adrienne Arsht Latin American...